Business

OmniAb Reports First Quarter 2026 Financial Results and Business Highlights

EMERYVILLE, Calif., May 07, 2026--OmniAb, Inc. (NASDAQ: OABI) today reported financial results for the three months ended March 31, 2026, provided operating and partner program updates, and increased 2026 financial guidance.

articleOmniab, Inc.May 7, 202613/company/omniab-inc/news/omniab-reports-first-quarter-2026-financial-results-and-business-highlights
OmniAb Reports First Quarter 2026 Financial Results and Business Highlights

About this update from Omniab, Inc.

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/b45ebe566839f2d612781cedb82ef2fc"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/oTA.azn7t9wBqXLkY3MgTw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MA--/https://media.zenfs.com/en/business-wire.com/b45ebe566839f2d612781cedb82ef2fc","width":960,"height":480},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/x.2tLawYmGRCHxjFR8CiZw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTMyMA--/https://media.zenfs.com/en/business-wire.com/b45ebe566839f2d612781cedb82ef2fc","width":640,"height":320},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/8iQr7NNjP7qzIljdyKY9WQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0/https://media.zenfs.com/en/business-wire.com/b45ebe566839f2d612781cedb82ef2fc","width":1024,"height":512}},"lazy":false},{"type":"text","content":"Conference Call Begins at 4:30 p.m. Eastern Time Today","length":54,"tagName":"p","attribs":{}},{"type":"text","content":"EMERYVILLE, Calif., May 07, 2026--(BUSINESS WIRE)--OmniAb, Inc. (NASDAQ: OABI) today reported financial results for the three months ended March 31, 2026, provided operating and partner program updates, and increased 2026 financial guidance.","length":241,"tagName":"p"},{"type":"text","content":""OmniAb experienced strong momentum during the first quarter as multiple partnered programs advanced into later-stage clinical development, reinforcing the diversity and value of our portfolio. With a very strong start to the year, we are raising our 2026 revenue guidance," stated Matt Foehr, Chief Executive Officer of OmniAb. "Continued progression of partner programs highlights the value of our technology platform and positions our business well for the future. Our innovation efforts continue to differentiate our platform as demonstrated by the launch of OmniUltra™ and our xPloration® partner access program."","length":638,"tagName":"p"},{"type":"text","content":"First Quarter 2026 Financial Results","length":36,"tagName":"p"},{"type":"text","content":"Revenue for the first quarter of 2026 was $14.4 million, compared with $4.2 million for the same period in 2025, with the increase primarily related to milestone revenue.","length":170,"tagName":"p"},{"type":"text","c...

More updates from Omniab, Inc.

operating expensesOmniAb, Inc.clinical developmentfinancial guidanceCash costs